Reviewing the significance of dendritic cell vaccines in interrupting breast cancer development

Decoding immunogenic cell death from a dendritic cell perspective

Targeting immunogenic cell death for glioma immunotherapy

Therapeutic cell-based vaccines for glioblastoma multiforme

Radioimmunotherapy With WT1 Dendritic Cell Vaccine for End-Stage Lung Adenocarcinoma Markedly Shrinks Tumors

The DC-T cell axis is an effective target for the treatment of non-small cell lung cancer

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients

WT1 Dendritic Cell Vaccine Therapy Improves Immune Profile and Prolongs Progression-Free Survival in End-Stage Lung Cancer

Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment

Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression